According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best insurance stocks to buy right now are:
1. Crawford & Co (NYSE:CRD.A)
The Component Grade breakdown for Crawford & Co (NYSE:CRD.A) is: Value: A, Growth: C, Momentum: C, Sentiment: C, Safety: B, Financials: B, and AI: B.
Crawford & Co (NYSE:CRD.A) has a Due Diligence Score of 51, which is 15 points higher than the insurance industry average of 36.
CRD.A passed 19 out of 38 due diligence checks and has strong fundamentals. Crawford & Co has seen its stock return 0.53% over the past year, overperforming other insurance stocks by 17 percentage points.
Crawford & Co has an average 1 year
price target of $14.00, an upside of 23.02% from Crawford & Co's current stock price of $11.38.
Crawford & Co stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Crawford & Co, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Corvel (NASDAQ:CRVL)
Corvel (NASDAQ:CRVL) is the #2 top insurance stock out of 21 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year.
Learn more.
The Component Grade breakdown for Corvel (NASDAQ:CRVL) is: Value: C, Growth: C, Momentum: D, Sentiment: C, Safety: B, Financials: B, and AI: C.
Corvel (NASDAQ:CRVL) has a Due Diligence Score of 40, which is 4 points higher than the insurance industry average of 36.
CRVL passed 13 out of 33 due diligence checks and has average fundamentals. Corvel has seen its stock lose -42.22% over the past year, underperforming other insurance stocks by -26 percentage points.
3. Marsh & Mclennan Companies (NYSE:MMC)
The Component Grade breakdown for Marsh & Mclennan Companies (NYSE:MMC) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: B, Financials: C, and AI: C.
Marsh & Mclennan Companies (NYSE:MMC) has a Due Diligence Score of 50, which is 14 points higher than the insurance industry average of 36.
MMC passed 18 out of 38 due diligence checks and has strong fundamentals. Marsh & Mclennan Companies has seen its stock lose -12.18% over the past year, overperforming other insurance stocks by 4 percentage points.
Marsh & Mclennan Companies has an average 1 year
price target of $212.42, an upside of 13.49% from Marsh & Mclennan Companies's current stock price of $187.17.
Marsh & Mclennan Companies stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Marsh & Mclennan Companies, 25% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a hold, while 8.33% have issued a Sell rating, and 0% have issued a Strong Sell.